Hormone replacement therapy after surgery for epithelial ovarian cancer

Review (3 studies, n=350) reports hormone replacement therapy may slightly improve overall survival in women who have undergone surgical treatment for epithelial ovarian cancer, but the certainty of the evidence is low.

Source:

Cochrane Database of Systematic Reviews